US5876951A
(en)
*
|
1993-03-31 |
1999-03-02 |
Cadus Pharmaceutical Corporation |
Yeast cells engineered to produce pheromone system protein surrogates and uses therefor
|
US6255059B1
(en)
|
1993-03-31 |
2001-07-03 |
Cadus Pharmaceutical Corporation |
Methods for identifying G protein coupled receptor effectors
|
US5789184A
(en)
*
|
1993-03-31 |
1998-08-04 |
Cadus Pharmaceutical Corporation |
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
|
US20030054402A1
(en)
*
|
1993-03-31 |
2003-03-20 |
Cadus Pharmaceutical Corporation |
Methods and compositions for identifying receptor effectors
|
US6864060B1
(en)
*
|
1993-03-31 |
2005-03-08 |
Cadus Technologies, Inc. |
Yeast cells expressing modified G proteins and methods of use therefor
|
US7416881B1
(en)
|
1993-03-31 |
2008-08-26 |
Cadus Technologies, Inc. |
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
|
US7235648B1
(en)
|
1993-03-31 |
2007-06-26 |
Cadus Technologies, Inc. |
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
|
US6100042A
(en)
*
|
1993-03-31 |
2000-08-08 |
Cadus Pharmaceutical Corporation |
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
|
US6150137A
(en)
*
|
1994-05-27 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Immunosuppressant target proteins
|
US5989808A
(en)
*
|
1994-06-14 |
1999-11-23 |
American Cyanamid Company |
Identification of compounds affecting specific interaction of peptide binding pairs
|
US5695941A
(en)
*
|
1994-06-22 |
1997-12-09 |
The General Hospital Corporation |
Interaction trap systems for analysis of protein networks
|
US6576236B1
(en)
|
1994-07-01 |
2003-06-10 |
Dana Farber Cancer Institute |
Methods for stimulating T cell responses by manipulating a common cytokine receptor γ chain
|
US6399296B1
(en)
|
1994-07-20 |
2002-06-04 |
The General Hospital Corporation |
Interaction trap systems for detecting protein interactions
|
WO1996002561A1
(en)
*
|
1994-07-20 |
1996-02-01 |
The General Hospital Corporation |
Interaction trap systems for detecting protein interactions
|
EP0775206A1
(de)
*
|
1994-07-22 |
1997-05-28 |
Novartis AG |
Duales hybridsystem
|
EP0830459B1
(de)
|
1995-04-11 |
2007-01-24 |
The General Hospital Corporation |
Reverse "two-hybrid"-systeme
|
US5637463A
(en)
*
|
1995-05-04 |
1997-06-10 |
Hoffmann-La Roche Inc. |
Method to detect protein-protein interactions
|
US5821048B1
(en)
*
|
1995-06-07 |
2000-05-23 |
Harvard College |
Methods kits and compositions for diagnosing papillomavirus infection
|
US5968802A
(en)
*
|
1995-06-07 |
1999-10-19 |
Wang; Bruce |
Nuclear cyclophilin
|
US20030215798A1
(en)
*
|
1997-06-16 |
2003-11-20 |
Diversa Corporation |
High throughput fluorescence-based screening for novel enzymes
|
EP0790304A1
(de)
*
|
1995-12-21 |
1997-08-20 |
AMERSHAM INTERNATIONAL plc |
Auf Nachweismethoden bezogene Verbesserungen
|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
WO1997044447A2
(en)
*
|
1996-05-03 |
1997-11-27 |
President And Fellows Of Harvard College |
Transcriptional activation system, activators, and uses therefor
|
US6083693A
(en)
*
|
1996-06-14 |
2000-07-04 |
Curagen Corporation |
Identification and comparison of protein-protein interactions that occur in populations
|
US5807708A
(en)
*
|
1996-07-30 |
1998-09-15 |
Millennium Pharmaceuticals, Inc. |
Conservin nucleic acid molecules and compositions
|
US5925523A
(en)
|
1996-08-23 |
1999-07-20 |
President & Fellows Of Harvard College |
Intraction trap assay, reagents and uses thereof
|
AU4159697A
(en)
*
|
1996-08-23 |
1998-03-06 |
President And Fellows Of Harvard College |
Interaction trap assay, reagents and uses thereof
|
ATE284972T1
(de)
*
|
1996-09-24 |
2005-01-15 |
Cadus Pharmaceutical Corp |
Verfahren und zusammensetzungen für die identifizierung von receptor effectoren
|
US6048693A
(en)
*
|
1996-10-16 |
2000-04-11 |
Bittech, Inc. |
Phenotypic assays of cyclin/cyclin-dependent kinase function
|
AU4903897A
(en)
*
|
1996-10-16 |
1998-05-11 |
Bittech, Inc. |
Phenotypic assays of cyclin/cyclin-dependent kinase function
|
US20020137890A1
(en)
*
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
DK0975755T3
(da)
|
1997-04-16 |
2007-06-11 |
Millennium Pharm Inc |
CRSP-protein (cysteinrige udskilte proteiner), nukleinsyremolekyler der koder herfor samt anvendelser deraf
|
US6426411B1
(en)
|
1997-05-30 |
2002-07-30 |
Dana-Farber Cancer Institute |
PGC-1, a novel brown fat pparγ coactivator
|
US5885779A
(en)
*
|
1997-09-09 |
1999-03-23 |
University Of British Columbia |
Repressed trans-activator system for characterization of protein-protein interactions
|
US6344554B1
(en)
|
1997-10-02 |
2002-02-05 |
Regents Of The University Of California |
Polynucleotide sequences from Candida albicans encoding polypeptides associated with filamentous growth
|
US6332897B1
(en)
*
|
1998-03-27 |
2001-12-25 |
Glaxo Wellcome Inc. |
Assay methods
|
US6355473B1
(en)
|
1998-05-06 |
2002-03-12 |
Cadus Pharmaceutical Corp. |
Yeast cells having mutations in stp22 and uses therefor
|
US6733991B1
(en)
|
1998-05-08 |
2004-05-11 |
Osi Pharmaceuticals, Inc. |
AGS proteins and nucleic acid molecules and uses therefor
|
US6746852B1
(en)
|
1998-05-08 |
2004-06-08 |
Osi Pharmaceuticals, Inc. |
AGS proteins and nucleic acid molecules and uses thereof
|
CA2256121A1
(en)
*
|
1998-06-08 |
1999-12-08 |
Hong Wang |
Cyclin-dependent kinase inhibitors as plant growth regulators
|
US7273747B2
(en)
*
|
1998-08-27 |
2007-09-25 |
Cadus Technologies, Inc. |
Cell having amplified signal transduction pathway responses and uses therefor
|
US6251605B1
(en)
|
1998-10-27 |
2001-06-26 |
Cadus Pharmaceutical Corporation |
Yeast cells having mutations in Cav1 and uses therefor
|
WO2000031261A2
(en)
*
|
1998-11-25 |
2000-06-02 |
Cadus Pharmaceutical Corporation |
Methods and compositions for identifying effectors of the formyl peptide receptor like-1 (fprl-1) receptor
|
US6504008B1
(en)
|
1999-02-01 |
2003-01-07 |
Cadus Technologies, Inc. |
Cell based signal generation
|
EP2301947A3
(de)
|
1999-02-26 |
2011-11-23 |
Millennium Pharmaceuticals, Inc. |
Sekretierte Proteine und Verwendungen dafür
|
CA2362414A1
(en)
|
1999-03-12 |
2000-09-14 |
Gpc Biotech, Inc. |
Methods and reagents for identifying synthetic genetic elements
|
US7396905B1
(en)
|
1999-05-21 |
2008-07-08 |
Mckeon Frank |
Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto
|
US6555325B1
(en)
*
|
1999-06-14 |
2003-04-29 |
Cadus Technologies, Inc. |
System for detection of a functional interaction between a compound and a cellular signal transduction component
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
CA2383456C
(en)
|
1999-08-23 |
2016-06-07 |
Clive Wood |
Pd-1, a receptor for b7-4, and uses therefor
|
US7223533B2
(en)
|
1999-09-10 |
2007-05-29 |
Cadus Technologies, Inc. |
Cell surface proteins and use thereof as indicators of activation of cellular signal transduction pathways
|
US20020061512A1
(en)
*
|
2000-02-18 |
2002-05-23 |
Kim Jin-Soo |
Zinc finger domains and methods of identifying same
|
WO2001064882A2
(en)
|
2000-02-29 |
2001-09-07 |
Millennium Pharmaceuticals, Inc. |
1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
US7029847B2
(en)
*
|
2000-05-16 |
2006-04-18 |
Massachusetts Institute Of Technology |
Methods and compositions for interaction trap assays
|
AU2001263155A1
(en)
*
|
2000-05-16 |
2001-11-26 |
Massachusetts Institute Of Technology |
Methods and compositions for interaction trap assays
|
US7049089B2
(en)
|
2000-05-30 |
2006-05-23 |
Bayer Aktiengesellschaft |
Regulation of human PLC delta-1
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
UA83458C2
(uk)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
|
CA2436805A1
(en)
|
2000-11-07 |
2002-10-17 |
Pioneer Hi-Bred International, Inc. |
Cell cycle nucleic acids, polypeptides and uses thereof
|
AU2002225914A1
(en)
*
|
2000-12-08 |
2002-06-18 |
Alexion Pharmaceuticals, Inc. |
Plasmid vectors
|
WO2002070678A2
(en)
|
2001-02-05 |
2002-09-12 |
Bayer Aktiengesellschaft |
Regulation of human serine/threonine protein kinase
|
WO2002074908A2
(en)
*
|
2001-03-02 |
2002-09-26 |
Mds Proteomics, Inc. |
Methods and reagents for regulating apoptosis
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
JP2004533226A
(ja)
|
2001-04-02 |
2004-11-04 |
ワイス |
B7−4に対するpd−1、aレセプター、およびその使用
|
MXPA03009415A
(es)
|
2001-04-16 |
2004-01-29 |
Wyeth Corp |
ESTRUCTURAS NOVEDOSAS DE LECTURA ABIERTA DE STREPTOCOCCUS PNEUMONIAE QUE CODIFICAN ANTIGENOS DE POLIPePTIDOS Y USOS DE LAS MISMAS.
|
US7244853B2
(en)
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
WO2002097097A2
(en)
|
2001-05-31 |
2002-12-05 |
Performance Plants, Inc. |
Compositions and methods of increasing stress tolerance in plants
|
AU2002367839A1
(en)
|
2001-07-16 |
2003-11-17 |
Hk Pharmaceuticals, Inc. |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
US7229774B2
(en)
|
2001-08-02 |
2007-06-12 |
Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
WO2003016571A1
(en)
*
|
2001-08-17 |
2003-02-27 |
Toolgen, Inc. |
Zinc finger domain libraries
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
JP2005514921A
(ja)
|
2001-11-09 |
2005-05-26 |
ダナ−ファーバー キャンサー インスティチュート インク |
PGC−1β、新規PGC−1相同体およびその用途
|
US7858297B2
(en)
|
2001-12-18 |
2010-12-28 |
Centre National De La Recherche Scientifique Cnrs |
Chemokine-binding protein and methods of use
|
DE60234713D1
(de)
|
2001-12-18 |
2010-01-21 |
Endocube Sas |
Neue mit dem zelltod assoziierte proteine aus der thap familie und par4 verwandte signalwege, die bei der kontrolle von apoptosis involviert sind
|
US7087418B2
(en)
|
2001-12-19 |
2006-08-08 |
Bristol-Myers Squibb Company |
Pichia pastoris formate dehydrogenase and uses therefor
|
EP1455815A4
(de)
|
2001-12-19 |
2006-11-02 |
Millennium Pharm Inc |
Mitglieder der familie der humanen diacylglycerol-acyltransferase 2 (dgat2) und ihre verwendung
|
EP1953244A1
(de)
|
2002-01-09 |
2008-08-06 |
Nakamura, Yusuke |
Krebsprofile
|
US20020094519A1
(en)
*
|
2002-03-07 |
2002-07-18 |
Agencourt Bioscience Corporation |
Detection of protein interactions
|
ATE421088T1
(de)
*
|
2002-03-11 |
2009-01-15 |
Caprotec Bioanalytics Gmbh |
Verbindungen und verfahren für die analyse des proteoms
|
US20040116658A1
(en)
*
|
2002-03-22 |
2004-06-17 |
Ken-Shwo Dai |
Human KAP/Cdi1-related gene variant associated with small cell lung cancer
|
GB0207533D0
(en)
|
2002-04-02 |
2002-05-08 |
Oxford Glycosciences Uk Ltd |
Protein
|
EP1900827A3
(de)
|
2002-05-21 |
2008-04-16 |
Bayer HealthCare AG |
Verfahren und Zusammensetzungen zur Vorhersage, Diagnose, Prognose, Verhinderung und Behandlung maligner Neoplasien
|
DK1572950T3
(da)
|
2002-06-17 |
2013-02-04 |
Thrasos Inc |
Enkeltdomæne TDF-relaterede forbindelser og analoger deraf
|
EP2311978A1
(de)
|
2002-08-20 |
2011-04-20 |
Millennium Pharmaceuticals, Inc. |
Zusammensetzungen, Kits und Verfahren zur Identifizierung, Beurteilung, Vorbeugung und Therapie von Gebärmutterhalskrebs
|
US20050037011A1
(en)
|
2002-11-21 |
2005-02-17 |
Jones Stephen N. |
Diagnosing and treating hematopoietic cancers
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
WO2004058052A2
(en)
|
2002-12-20 |
2004-07-15 |
Applera Corporation |
Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
|
DK2259068T3
(en)
*
|
2003-01-16 |
2013-11-11 |
Caprotec Bioanalytics Gmbh |
Capture compounds and methods for analyzing the proteome
|
KR20060031809A
(ko)
|
2003-06-09 |
2006-04-13 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
암 치료 및 진단용 조성물 및 방법
|
WO2005014795A2
(en)
|
2003-08-08 |
2005-02-17 |
Genenews Inc. |
Osteoarthritis biomarkers and uses thereof
|
EP1892306A3
(de)
|
2003-10-06 |
2008-06-11 |
Bayer HealthCare AG |
Verfahren und Kit zur Untersuchung von Krebs
|
US7799518B2
(en)
|
2003-10-07 |
2010-09-21 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
WO2005056837A2
(en)
|
2003-11-26 |
2005-06-23 |
Applera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
EP2423327B1
(de)
|
2004-05-07 |
2014-01-08 |
Celera Corporation |
Genetischer Polymorphismus und Leberfibrose, Verfahren zur Erkennung und Verwendung davon
|
US7858323B2
(en)
|
2004-06-09 |
2010-12-28 |
The Regents Of The University Of Michigan |
Phage microarray profiling of the humoral response to disease
|
AU2005265098B2
(en)
|
2004-06-17 |
2012-02-23 |
Thrasos Innovation, Inc. |
TDF-related compounds and analogs thereof
|
US9944713B2
(en)
|
2004-11-24 |
2018-04-17 |
Medicinal Bioconvergence Research Center |
Antibody specific to the AIMP2-DX2
|
US7459529B2
(en)
|
2004-11-24 |
2008-12-02 |
Seoul National University Industry Foundation |
AIMP2-DX2 and its uses
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
EP2110667A1
(de)
|
2005-01-20 |
2009-10-21 |
University Of Rochester |
Mit Thioredoxin interagierendes Protein (TXNIP) als Regulator der Gefäßfunktion
|
CA2599589A1
(en)
|
2005-02-07 |
2006-08-17 |
Genenews,Inc. |
Mild osteoarthritis biomarkers and uses thereof
|
EP1695981A1
(de)
|
2005-02-25 |
2006-08-30 |
Forschungsverbund Berlin e.V. |
Verfahren zum Redox-Potential-abhängigen Nachweis von Targetmolekülen durch wechselwirkende Polypeptide
|
EP2113572B1
(de)
|
2005-03-11 |
2012-12-05 |
Celera Corporation |
Mit koronarer Herzkrankheit assoziierte genetische Polymorphismen, Nachweisverfahren und deren Verwendungen
|
CN101495116A
(zh)
|
2005-03-22 |
2009-07-29 |
哈佛大学校长及研究员协会 |
蛋白降解病症的治疗
|
JP2008536869A
(ja)
|
2005-04-15 |
2008-09-11 |
プレジデント・アンド・フエローズ・オブ・ハーバード・カレツジ |
Krc活性を調節することによる骨形成および石灰化の調節方法
|
AU2006259583A1
(en)
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
US9957569B2
(en)
|
2005-09-12 |
2018-05-01 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
AU2006291054B2
(en)
|
2005-09-12 |
2011-10-13 |
The Brigham And Women's Hospital, Inc. |
Recurrent gene fusions in prostate cancer
|
EP1945258A4
(de)
|
2005-09-20 |
2011-08-17 |
Thrasos Therapeutics Inc |
Mit tdf verwandte verbindungen und analoga davon
|
US7799530B2
(en)
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
WO2007047907A2
(en)
|
2005-10-14 |
2007-04-26 |
The Regents Of The University Of Michigan |
Dek protein compositions and methods of using the same
|
EP2319941A3
(de)
|
2005-10-21 |
2011-08-17 |
GeneNews Inc. |
Methode und vorrichtung zur korrelation von biomarker produktmengen mit krankheiten
|
ES2547421T3
(es)
|
2005-10-31 |
2015-10-06 |
Oncomed Pharmaceuticals, Inc. |
Composiciones y métodos para diagnosticar y tratar el cáncer
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
WO2007081804A2
(en)
|
2006-01-05 |
2007-07-19 |
Immune Disease Institute, Inc. |
Regulators of nfat
|
AR059448A1
(es)
|
2006-02-13 |
2008-04-09 |
Divergence Inc |
Polipeptidos quimericos vegetales de union para el reconocimiento molecular universal
|
WO2008091349A1
(en)
|
2006-02-14 |
2008-07-31 |
The President And Fellows Of Harvard College |
Bifunctional histone deacetylase inhibitors
|
AU2007248656B2
(en)
|
2006-05-03 |
2013-04-04 |
Dana-Farber Cancer Institute, Inc. |
Histone deacetylase and tubulin deacetylase inhibitors
|
AU2007257162A1
(en)
|
2006-06-05 |
2007-12-13 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
US7910303B2
(en)
|
2006-10-20 |
2011-03-22 |
Celera Corporation |
Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
|
WO2008104803A2
(en)
|
2007-02-26 |
2008-09-04 |
Oxford Genome Sciences (Uk) Limited |
Proteins
|
EP3118221B1
(de)
|
2007-02-26 |
2019-08-21 |
Oxford BioTherapeutics Ltd |
Proteine
|
EP2243834A1
(de)
|
2007-03-05 |
2010-10-27 |
Cancer Care Ontario |
Abschätzung des Kolorektalkarzinomrisikos
|
CA2687964A1
(en)
|
2007-06-01 |
2009-02-19 |
The Trustees Of Princeton University |
Treatment of viral infections by modulation of host cell metabolic pathways
|
PL3009148T3
(pl)
|
2007-07-02 |
2019-03-29 |
Oncomed Pharmaceuticals, Inc. |
Kompozycje oraz sposoby leczenia i diagnozowania nowotworu
|
AU2008275303B2
(en)
|
2007-07-06 |
2012-05-03 |
The Regents Of The University Of Michigan |
MIPOL1-ETV1 gene rearrangements
|
EP3018216B1
(de)
|
2007-07-06 |
2018-09-12 |
The Regents Of The University Of Michigan |
Rezidivierende genfusionen bei prostatakrebs
|
US8586081B2
(en)
|
2007-09-20 |
2013-11-19 |
University Of Massachusetts |
Detoxified recombinant botulinum neurotoxin
|
US8039212B2
(en)
|
2007-11-05 |
2011-10-18 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
CA2705486C
(en)
|
2007-11-19 |
2019-04-02 |
Celera Corporation |
Lung cancer markers and uses thereof
|
US20090221620A1
(en)
|
2008-02-20 |
2009-09-03 |
Celera Corporation |
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
EP3093351B1
(de)
|
2008-07-09 |
2018-04-18 |
Celera Corporation |
Mit kardiovaskulären krankheiten assoziierte, genetische polymorphismen, verfahren zum nachweis und verwendungen davon
|
RU2515611C2
(ru)
|
2008-07-23 |
2014-05-20 |
Президент Энд Феллоуз Оф Гарвард Колледж |
Ингибиторы деацетилазы и их применение
|
US8815794B2
(en)
|
2008-08-28 |
2014-08-26 |
The Research Foundation For The State University Of New York |
Treatment of amyloidoses using myelin basic protein and fragments thereof
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
NZ592338A
(en)
|
2008-09-26 |
2012-11-30 |
Oncomed Pharm Inc |
Frizzled-binding agents and uses thereof
|
US9207242B2
(en)
|
2008-10-09 |
2015-12-08 |
The University Of Hong Kong |
Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
|
BRPI0921150B1
(pt)
|
2008-11-11 |
2022-05-10 |
The Regents Of The University Of Michigan |
Uso de um antagonista de cxcr1 para o tratamento de tumor
|
WO2010080985A1
(en)
|
2009-01-08 |
2010-07-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
KR20110111474A
(ko)
|
2009-01-09 |
2011-10-11 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
암에서의 반복적 유전자 융합체
|
WO2010084408A2
(en)
|
2009-01-21 |
2010-07-29 |
Oxford Biotherapeutics Ltd. |
Pta089 protein
|
WO2010118435A2
(en)
|
2009-04-10 |
2010-10-14 |
Tufts Medical Center, Inc. |
Par-1 activation by metalloproteinase-1 (mmp-1)
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
CA2774349C
(en)
|
2009-09-17 |
2019-03-19 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
WO2011054007A1
(en)
|
2009-11-02 |
2011-05-05 |
Oxford Biotherapeutics Ltd. |
Ror1 as therapeutic and diagnostic target
|
EP3168232B1
(de)
|
2009-11-13 |
2021-09-29 |
Dana-Farber Cancer Institute, Inc. |
Zusammensetzungen, kits und verfahren zur diagnose, prognose, überwachung, behandlung und modulierung von auf transplantationen folgenden lymphoproliferativen erkrankungen und hypoxievermittelten angiogeneseerkrankungen mithilfe von galectin-1
|
WO2011063198A2
(en)
|
2009-11-20 |
2011-05-26 |
St. Jude Children's Research Hospital |
Methods and compositions for modulating the activity of the interleukin-35 receptor complex
|
US9926593B2
(en)
|
2009-12-22 |
2018-03-27 |
Sequenom, Inc. |
Processes and kits for identifying aneuploidy
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Wnt拮抗劑及治療和篩選方法
|
US9745589B2
(en)
|
2010-01-14 |
2017-08-29 |
Cornell University |
Methods for modulating skeletal remodeling and patterning by modulating SHN2 activity, SHN3 activity, or SHN2 and SHN3 activity in combination
|
JP2013520162A
(ja)
|
2010-01-22 |
2013-06-06 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
代謝障害の同定、査定、予防および治療のための組成物、キットおよび方法
|
WO2011116209A2
(en)
|
2010-03-17 |
2011-09-22 |
The Regents Of The University Of Michigan |
Using phage epitopes to profile the immune response
|
CN107098958B
(zh)
|
2010-03-26 |
2021-11-05 |
达特茅斯大学理事会 |
Vista调节性t细胞介体蛋白、vista结合剂及其用途
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
AU2011235904B2
(en)
|
2010-04-01 |
2015-10-08 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
US20110269735A1
(en)
|
2010-04-19 |
2011-11-03 |
Celera Corporation |
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
GB201012420D0
(en)
|
2010-07-23 |
2010-09-08 |
Univ Erasmus Medical Ct |
Foetal heamoglobin inhibitor
|
WO2012051301A1
(en)
|
2010-10-12 |
2012-04-19 |
President And Fellows Of Harvard College |
Methods for identifying modulators of triglyceride metabolism, for modulating triglyceride metabolism and for identifying subjects at risk for abnormal triglyceride metabolism
|
US20120108651A1
(en)
|
2010-11-02 |
2012-05-03 |
Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) |
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
US8945556B2
(en)
|
2010-11-19 |
2015-02-03 |
The Regents Of The University Of Michigan |
RAF gene fusions
|
WO2012109238A2
(en)
|
2011-02-07 |
2012-08-16 |
President And Fellows Of Harvard College |
Methods for increasing immune responses using agents that directly bind to and activate ire-1
|
US20140157443A1
(en)
|
2011-04-14 |
2014-06-05 |
St. Jude Children's Research Hospital |
Methods and compositions for detecting and modulating a novel mtor complex
|
TWI560200B
(en)
|
2011-05-25 |
2016-12-01 |
Innate Pharma Sa |
Anti-kir antibodies for the treatment of inflammatory and autoimmune disorders
|
LT2726094T
(lt)
|
2011-06-28 |
2017-02-10 |
Oxford Biotherapeutics Ltd |
Gydymo ir diagnozavimo objektas
|
US10093705B2
(en)
|
2011-09-13 |
2018-10-09 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using FNDC5
|
AU2012312520A1
(en)
|
2011-09-20 |
2014-05-08 |
The University Of North Carolina At Chapel Hill |
Regulation of sodium channels by PLUNC proteins
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
EP2814844B1
(de)
|
2012-02-15 |
2017-08-02 |
Novo Nordisk A/S |
Antikörper, die den auslösenden rezeptor binden und blockieren, der auf myeloid-zellen-1 (trem-1) exprimiert ist
|
CN104203977A
(zh)
|
2012-02-15 |
2014-12-10 |
诺和诺德A/S(股份有限公司) |
结合肽聚糖识别蛋白1的抗体
|
ES2930180T3
(es)
|
2012-03-02 |
2022-12-07 |
Sequenom Inc |
Métodos para enriquecer ácido nucleico canceroso a partir de una muestra biológica
|
US10105351B2
(en)
|
2012-03-14 |
2018-10-23 |
University Of Central Florida Research Foundation, Inc. |
Neurofibromatoses therapeutic agents and screening for same
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
EP2858648B1
(de)
|
2012-06-07 |
2018-08-22 |
Beth Israel Deaconess Medical Center, Inc. |
Verfahren und zusammensetzungen zur pin1-hemmung
|
CN104619722B
(zh)
|
2012-06-22 |
2022-10-04 |
达特茅斯大学理事会 |
新型vista-ig构建体和vista-ig用于治疗自身免疫性、过敏性和炎性疾病的用途
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
EP2872648B1
(de)
|
2012-07-13 |
2019-09-04 |
Sequenom, Inc. |
Verfahren und zusammensetzungen zur methylierungsbasierten anreicherung fetaler nukleinsäure aus einer mütterlichen probe für nicht-invasive pränatale diagnosen
|
GB201213652D0
(en)
|
2012-08-01 |
2012-09-12 |
Oxford Biotherapeutics Ltd |
Therapeutic and diagnostic target
|
JP6368308B2
(ja)
|
2012-09-07 |
2018-08-01 |
トラスティーズ・オブ・ダートマス・カレッジ |
癌の診断および治療のためのvista調節剤
|
US20160046997A1
(en)
|
2012-10-18 |
2016-02-18 |
Oslo Universitetssykehus Hf |
Biomarkers for cervical cancer
|
US9266959B2
(en)
|
2012-10-23 |
2016-02-23 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using frizzled-binding agents
|
US9359444B2
(en)
|
2013-02-04 |
2016-06-07 |
Oncomed Pharmaceuticals Inc. |
Methods and monitoring of treatment with a Wnt pathway inhibitor
|
GB201302447D0
(en)
|
2013-02-12 |
2013-03-27 |
Oxford Biotherapeutics Ltd |
Therapeutic and diagnostic target
|
US11060145B2
(en)
|
2013-03-13 |
2021-07-13 |
Sequenom, Inc. |
Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
AU2014275166B2
(en)
|
2013-06-06 |
2020-09-10 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for identification, assessment prevention, and treatment of cancer using PD-L1 isoforms
|
US20160175401A1
(en)
|
2013-07-31 |
2016-06-23 |
Dana-Farber Cancer Institute Inc. |
Compoitions and methods for modulating thermogenesis using pth-related and egf-related compounds
|
ES2724300T3
(es)
|
2013-09-25 |
2019-09-10 |
Univ Cornell |
Compuestos para inducir inmunidad antitumoral y métodos de lo mismo
|
DK3087098T3
(da)
|
2013-12-24 |
2020-06-08 |
Janssen Pharmaceutica Nv |
Anti-Vista-antistoffer og -fragmenter
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
EP3736344A1
(de)
|
2014-03-13 |
2020-11-11 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
CA2951885C
(en)
|
2014-06-11 |
2023-07-04 |
Kathy A. Green |
Use of vista agonists and antagonists to suppress or enhance humoral immunity
|
WO2016011265A2
(en)
|
2014-07-17 |
2016-01-21 |
Beth Israel Deaconess Medical Center, Inc. |
Biomarkers for pin1-associated disorders
|
CN106536559B
(zh)
|
2014-07-17 |
2021-04-27 |
诺和诺德股份有限公司 |
定点诱变trem-1抗体以降低黏度
|
WO2016011268A1
(en)
|
2014-07-17 |
2016-01-21 |
Beth Israel Deaconess Medical Center, Inc. |
Atra for modulating pin1 activity and stability
|
AU2015357463B2
(en)
|
2014-12-05 |
2021-10-07 |
Immunext, Inc. |
Identification of VSIG8 as the putative vista receptor and its use thereof to produce vista/VSIG8 modulators
|
ES2805206T3
(es)
|
2015-03-10 |
2021-02-11 |
Univ Massachusetts |
Enfoque dirigido a GDF6 y a señalización de BMP para la terapia contra el melanoma
|
WO2016145186A1
(en)
|
2015-03-12 |
2016-09-15 |
Beth Israel Deaconess Medical Center, Inc. |
Enhanced atra-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions
|
US11009509B2
(en)
|
2015-06-24 |
2021-05-18 |
Janssen Pharmaceutica Nv |
Anti-VISTA antibodies and fragments
|
WO2017075329A2
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
TW202216201A
(zh)
|
2016-02-12 |
2022-05-01 |
比利時商楊森製藥公司 |
抗vista抗體及片段、其用途及鑑定其之方法
|
WO2017162659A1
(en)
|
2016-03-24 |
2017-09-28 |
Bayer Pharma Aktiengesellschaft |
Intracellular hepsin as therapeutic target for the treatment of cancer with centrosome amplification
|
CN117562992A
(zh)
|
2016-04-15 |
2024-02-20 |
伊穆奈克斯特股份有限公司 |
抗人vista抗体及其用途
|
KR20200139219A
(ko)
|
2018-04-02 |
2020-12-11 |
브리스톨-마이어스 스큅 컴퍼니 |
항-trem-1 항체 및 이의 용도
|